Immune thrombocytopenic purpura

Results: 50



#Item
11ITP Patient Information Leaflet  on immune thrombocytopenia ! !

ITP Patient Information Leaflet on immune thrombocytopenia ! !

Add to Reading List

Source URL: www.itpsupport.org.uk

Language: English - Date: 2014-12-30 15:26:50
12Review article  International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan,1 Roberto Stasi,2 Adrian C. Newland,1 Victor S. Blanchette,3 Paula Bolton-Maggs,4 James B.

Review article International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan,1 Roberto Stasi,2 Adrian C. Newland,1 Victor S. Blanchette,3 Paula Bolton-Maggs,4 James B.

Add to Reading List

Source URL: www.itpsupport.org.uk

Language: English - Date: 2011-03-24 19:02:24
13The ITP Support Immune Association thrombocytopenia REG. CHARITY NOwww.itpsupport.org.uk

The ITP Support Immune Association thrombocytopenia REG. CHARITY NOwww.itpsupport.org.uk

Add to Reading List

Source URL: www.itpsupport.org.uk

Language: English - Date: 2014-08-20 13:23:07
14INTRAVENOUS IMMUNOGLOBULINS IN THE THERAPY OF IMMUNE-MEDIATED HEMATOLOGIC DISORDERS Susan G. Hackner, BVSc.MRCVS.DACVIM. DACVECC. Intravenous immunoglobulin (IVIG) is used for the treatment of numerous immunodeficiency,

INTRAVENOUS IMMUNOGLOBULINS IN THE THERAPY OF IMMUNE-MEDIATED HEMATOLOGIC DISORDERS Susan G. Hackner, BVSc.MRCVS.DACVIM. DACVECC. Intravenous immunoglobulin (IVIG) is used for the treatment of numerous immunodeficiency,

Add to Reading List

Source URL: www.cuvs.org

Language: English - Date: 2011-11-14 09:20:40
15Immunoglobulin Replacement Therapy in Primary Immune Deficiency (PID) Diseases ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION Immunoglobulin (antibody) replacement therapy is one of the most important and successful

Immunoglobulin Replacement Therapy in Primary Immune Deficiency (PID) Diseases ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION Immunoglobulin (antibody) replacement therapy is one of the most important and successful

Add to Reading List

Source URL: www.allergy.org.au

Language: English - Date: 2014-01-06 23:51:33
16HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN . Privigen®, Immune Globulin Intrave

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN . Privigen®, Immune Globulin Intrave

Add to Reading List

Source URL: labeling.cslbehring.com

Language: English - Date: 2013-12-11 15:13:04
17Monoclonal human antibody against HPA-5b (human platelet antigen 5b) Product reference: DDX9021 Description Neonatal AlloImmune Thrombocytopenia (NAIT) is the commonest cause of severe isolated thrombocytopenia in the fo

Monoclonal human antibody against HPA-5b (human platelet antigen 5b) Product reference: DDX9021 Description Neonatal AlloImmune Thrombocytopenia (NAIT) is the commonest cause of severe isolated thrombocytopenia in the fo

Add to Reading List

Source URL: www.dendritics.net

Language: English - Date: 2014-09-04 08:42:16
18Monoclonal human antibody against GPIa-IIa (human platelet antigen) Product reference: DDX9022 Description Neonatal AlloImmune Thrombocytopenia (NAIT) is the commonest cause of severe isolated thrombocytopenia in the foe

Monoclonal human antibody against GPIa-IIa (human platelet antigen) Product reference: DDX9022 Description Neonatal AlloImmune Thrombocytopenia (NAIT) is the commonest cause of severe isolated thrombocytopenia in the foe

Add to Reading List

Source URL: www.dendritics.net

Language: English - Date: 2014-09-04 08:56:47
19Intravenous immunoglobulin / Immune system / Gamma globulin / Infusion set / Antibody / Common variable immunodeficiency / Idiopathic thrombocytopenic purpura / Biology / Glycoproteins / Medicine

UM.SCIG 0018 Ver 1.0 Template made available through the BC Provincial Blood Coordinating Office Release Date: [removed] Page 1 of 1 Subcutaneous Immune Globulin (SCIG) Home Infusion Program Patient Re

Add to Reading List

Source URL: www.pbco.ca

Language: English - Date: 2014-08-01 11:50:11
20Tolerability and Pharmacokinetic Comparison of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases

Tolerability and Pharmacokinetic Comparison of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases

Add to Reading List

Source URL: www.fda.gov

Language: English